Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice

被引:0
作者
Arbeit, JM
Riley, RR
Huey, B
Porter, C
Kelloff, G
Lubet, R
Ward, JM
Pinkel, D
机构
[1] Univ Calif San Francisco, Mt Zion Med Ctr, Dept Surg, San Francisco, CA 94143 USA
[2] NCI, Div Canc Chemoprevent, Bethesda, MD 20262 USA
[3] Roswell Pk Mem Canc Ctr, Grace Canc Drug Ctr, Buffalo, NY 14263 USA
[4] NCI, Off Lab & Anim Sci, Vet & Tumor Pathol Sect, Frederick, MD 21702 USA
[5] Univ Calif San Francisco, Ctr Canc, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To be informative for chemoprevention, animal models must both closely emulate human disease and possess surrogate endpoint biomarkers that facilitate rapid drug screening. This study elucidated site-specific histopathological and biochemical surrogate endpoint biomarkers of spontaneous epidermal carcinogenesis in K14-HPV16 transgenic mice and demonstrated that the incidence and severity of these markers were decreased by the ornithine decarboxylase (ODC) inhibitor difluoromethylornithine (DFMO), The cumulative incidence of visible epidermal cancers in 127 untreated transgenic mice was 42% by 52 weeks of age, most frequently affecting the chest as flat lesions in association with chronic ulcers, or in the ear as protuberant masses. Microscopic malignancies were detected in 39% of 32-week-old transgenic mice and were found to emerge from precursor lesions that were of two distinct types: dysplastic sessile ear papillomas and hyperproliferative follicular/interfollicular chest dysplasias, ODC activity and tissue polyamine contents were differentially elevated in ear and chest skin during carcinogenesis, such that there was a marked elevation of both parameters of polyamine metabolism as early as 4 weeks of age in the ear, whereas in the chest, polyamine metabolism was increased significantly only in the late stages of neoplastic progression and in epidermal cancers. Administration of 1.0% DFMO in the drinking water from 4 to 32 weeks of age prevented both visible and microscopic malignancies and significantly decreased the incidence of chest and ear precursor lesions, ODC activity and tissue putrescine content were markedly diminished by DFMO chemoprevention in ear skin, whereas there was a more modest decline of these parameters in chest skin. DFMO treatment of transgenic mice from 28 to 32 weeks of age was associated with an absence of ear cancer and a marked regression of dysplastic papillomas, In contrast, the results in chest skin were complex in that the severity of chest precursors diminished, but their incidence was unchanged, and microscopic cancers were still detectable within these lesions. Collectively, this study highlights the utility of multistage epidermal carcinogenesis in K14-HPV16 transgenic mice both for the study of the biology of, and as a screening tool for, novel drugs and chemopreventive regimens.
引用
收藏
页码:3610 / 3620
页数:11
相关论文
共 50 条
  • [31] Ptaquiloside from bracken (Pteridiumspp.) promotes oral carcinogenesis initiated by HPV16 in transgenic mice
    Gil da Costa, Rui M.
    Neto, Tiago
    Estevao, Diogo
    Moutinho, Magda
    Felix, Ana
    Medeiros, Rui
    Lopes, Carlos
    Bastos, Margarida M. S. M.
    Oliveira, Paula A.
    [J]. FOOD & FUNCTION, 2020, 11 (04) : 3298 - 3305
  • [32] Chemoprevention of mammary carcinogenesis in a transgenic mouse model by α-difluoromethylornithine (DFMO) in the diet is associated with decreased cyclin D1 activity
    M Li
    S Ren
    M T Tilli
    J A Flaws
    R Lubet
    C J Grubbs
    P A Furth
    [J]. Oncogene, 2003, 22 : 2568 - 2572
  • [33] Chemoprevention of mammary carcinogenesis in a transgenic mouse model by α-difluoromethylornithine (DFMO) in the diet is associated with decreased cyclin D1 activity
    Li, ML
    Ren, SX
    Tilli, MT
    Flaws, JA
    Lubet, R
    Grubbs, CJ
    Furth, PA
    [J]. ONCOGENE, 2003, 22 (17) : 2568 - 2572
  • [34] DEVELOPMENT OF AN EPIDERMAL TRANSGENIC MOUSE MODEL TO STUDY HPV18 INDUCED CARCINOGENESIS
    WANG, XJ
    GREENHALGH, DA
    ECKHARDT, JN
    BUNDMAN, DS
    LONGLEY, MA
    ROTHNAGEL, JA
    SCHLEGEL, R
    ROOP, DR
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 228 - 228
  • [35] Bioactivity of betulinic acid nanoemulsions on skin carcinogenesis in transgenic mice K14E6
    Agame-Lagunes, B.
    Alegria-Rivadeneyra, M.
    Alexander-Aguilera, A.
    Quintana-Castro, R.
    Torres-Palacios, C.
    Grube-Pagola, P.
    Cano-Sarmiento, C.
    Garcia-Varela, R.
    Garcia, H. S.
    [J]. GRASAS Y ACEITES, 2021, 72 (04)
  • [36] The temporal and spatial expression of Claudins in epidermal development and the accelerated program of epidermal differentiation in K14-CaSR transgenic mice
    Troy, Tammy-Claire
    Li, Yuhua
    O'Malley, Lauren
    Turksen, Kursad
    [J]. GENE EXPRESSION PATTERNS, 2007, 7 (04) : 423 - 430
  • [37] The Cyclooxigenase-2 Inhibitor Parecoxib Prevents Epidermal Dysplasia in HPV16-Transgenic Mice: Efficacy and Safety Observations
    Ferreira, Tiago
    Campos, Sandra
    Silva, Monica G.
    Ribeiro, Rita
    Santos, Susana
    Almeida, Jose
    Pires, Maria Joao
    Gil da Costa, Rui Miguel
    Cordova, Claudia
    Nogueira, Antonio
    Neuparth, Maria Joao
    Medeiros, Rui
    da Silva Monteiro Bastos, Margarida Maria
    Gaivao, Isabel
    Peixoto, Francisco
    Oliveira, Maria Manuel
    Oliveira, Paula Alexandra
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (16)
  • [38] Human keratin 14 driven HPV 16 E6/E7 transgenic mice exhibit hyperkeratinosis
    Kim, SH
    Kim, KS
    Lee, EJ
    Kim, MO
    Park, JH
    Cho, KI
    Imakawa, K
    Hyun, BH
    Chang, KT
    Lee, HT
    Ryoo, ZY
    [J]. LIFE SCIENCES, 2004, 75 (25) : 3035 - 3042
  • [39] Laurencia johnstonii extract reverses early lesions in the K14E7HPV16 murine cervical carcinogenesis model
    Arvizu-Hernandez, Erandi
    Hernandez-Guerrero, Claudia Judith
    Alvarez-Rios, Elizabeth
    Gariglio, Patricio
    Cornejo-Garrido, Jorge
    Ocadiz-Delgado, Rodolfo
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (04)
  • [40] PROGRESSIVE SQUAMOUS EPITHELIAL NEOPLASIA IN K14-HUMAN PAPILLOMAVIRUS TYPE-16 TRANSGENIC MICE
    ARBEIT, JM
    MUNGER, K
    HOWLEY, PM
    HANAHAN, D
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (07) : 4358 - 4368